封面
市场调查报告书
商品编码
1650686

全球血管移植市场

Vascular Grafts

出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 481 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年,全球血管移植市场将达到 59 亿美元

2024 年全球血管移植市场规模估计为 39 亿美元,预计到 2030 年将达到 59 亿美元,2024-2030 年分析期内的复合年增长率为 7.2%。血管内动脉瘤修復 (EVAR) 适应症是报告中分析的细分市场之一,预计复合年增长率为 6.9%,到分析期结束时将达到 26 亿美元。在分析期内,週边血管修復指征部分预计将以 8.7% 的复合年增长率成长。

美国市场规模估计为 15 亿美元,中国市场预估年复合成长率为 8.9%

预计2024年美国血管移植市场规模将达15亿美元。中国是世界第二大经济体,预计到 2030 年市场规模将达到 6.876 亿美元,2024-2030 年分析期间的复合年增长率为 8.9%。其他值得注意的区域市场包括日本和加拿大,预计在分析期间的复合年增长率分别为 6.5% 和 6.4%。在欧洲,预计德国的复合年增长率约为 7.1%。

全球血管移植市场 - 主要趋势与驱动因素摘要

什么是血管移植?

血管移植是用于替换、修復或绕过体内部分血管的医疗设备,用于治疗动脉硬化、动脉瘤和阻塞等疾病。这些移植物对于冠状动脉绕道手术手术等心血管手术至关重要,可以改善心臟的血液流动。这些植入物使用的材料是根据其与人体的兼容性以及灵活性和耐用性等机械性能专门选择的。血管移植可以由聚酯或聚四氟乙烯(PTFE)等合成材料製成,也可以由人体或动物组织修饰的生物材料製成。

科技进步如何改善血管移植技术?

血管移植技术的最新创新显着改善了血管外科手术的结果。促进细胞增殖和再生的组织工程植入物的开发是该领域进步的一个例子。这些移植物具有高度的生物相容性,旨在促进内皮化,即移植物内表面新内皮细胞的生长,从而降低血栓症的风险并确保移植物的长期通畅性。此外,影像技术的进步提高了移植物放置的准确性,并最大限度地减少了手术期间的潜在风险和併发症。药物释放型移植物等技术创新有助于预防感染和血管再阻塞,使血管介入治疗更有效、更安全。

血管移植在血管疾病的治疗中扮演什么角色?

血管移植在各种血管疾病的治疗中起着至关重要的作用,如果不及时治疗,可能会导致严重的併发症甚至死亡。对于患有冠状动脉疾病的患者,可以使用血管移植来绕过阻塞的动脉并恢復心臟的正常血流。对于患有周边动脉疾病的患者,这些移植物可以绕过腿部患病动脉,缓解疼痛和痉挛等症状并防止截肢。对于动脉瘤,尤其是腹部主动脉血管瘤,移植物可以加强脆弱的动脉壁,防止其破裂。血管移植的多功能性和适应性使其成为血管外科手术中必不可少的工具,为高风险患者提供挽救生命的治疗。

血管移植市场的成长将受到多种因素的推动

血管移植市场的成长受到多种因素的推动,包括由于人口老化导致全球心血管疾病盛行率增加以及糖尿病、肥胖症和高血压等风险因素的增加。提高移植物功能和患者相容性的技术进步也促进了该市场的扩张。人们越来越偏好采用更小、更先进的移植物进行微创手术,以减少恢復时间并改善患者的治疗效果。此外,新兴国家医疗支出的增加和更先进医疗设施的出现,也扩大了血管移植手术的可近性。大众对心血管疾病早期诊断和治疗益处的认识不断提高,进一步刺激了市场成长,并凸显了血管移植在现代医疗实践中的重要性。

部分

适应症(血管内动脉瘤修復 (EVAR)、週边血管修復、血液透析机通路);原料(聚酯、ePTFE、聚氨酯、生物合成材料);最终用途(医院、门诊手术中心)

受访公司范例(44家值得关注的公司)

  • Cardinal Health, Inc.
  • Baxter International, Inc.
  • Terumo Corporation
  • Cook Medical, LLC
  • Teleflex, Inc.
  • LeMaitre Vascular, Inc.
  • MicroPort Scientific Corporation
  • iVascular SLU
  • Jotec GmbH
  • ParaGen Technologies
  • sunnatech scientific corporation
  • Vacis
  • Cardiovascular Systems, Inc.
  • Healionics
  • InnAVasc Medical

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章 市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲国家
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 竞赛

简介目录
Product Code: MCP15453

Global Vascular Grafts Market to Reach US$5.9 Billion by 2030

The global market for Vascular Grafts estimated at US$3.9 Billion in the year 2024, is expected to reach US$5.9 Billion by 2030, growing at a CAGR of 7.2% over the analysis period 2024-2030. Endovascular Aneurysm Repair (EVAR) Indication, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$2.6 Billion by the end of the analysis period. Growth in the Peripheral Vascular Repair Indication segment is estimated at 8.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.5 Billion While China is Forecast to Grow at 8.9% CAGR

The Vascular Grafts market in the U.S. is estimated at US$1.5 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$687.6 Million by the year 2030 trailing a CAGR of 8.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.5% and 6.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.1% CAGR.

Global Vascular Grafts Market - Key Trends & Drivers Summarized

What Are Vascular Grafts, and Why Are They Critical in Modern Medicine?

Vascular grafts are medical devices used to replace, repair, or bypass sections of blood vessels in the body, often necessitated by diseases such as atherosclerosis, aneurysms, or blockages. These grafts are crucial in cardiovascular surgeries, including coronary artery bypass grafting, which helps improve blood flow to the heart. The materials used for these grafts are specifically chosen based on their compatibility with the human body and their mechanical properties, such as flexibility and durability. Vascular grafts can be made from synthetic materials like polyester and polytetrafluoroethylene (PTFE), or from biological materials, including modified human or animal tissue.

How Have Innovations Enhanced Vascular Graft Technology?

Recent innovations in vascular graft technology have significantly improved the outcomes of vascular surgeries. The development of tissue-engineering grafts, which promote cell growth and regeneration, is one example of how this field is advancing. These grafts are designed to be biocompatible and to encourage endothelialization, where new endothelial cells grow on the inner surface of the graft, thereby reducing the risk of thrombosis and ensuring the long-term patency of the graft. Additionally, advancements in imaging and diagnostic technologies have improved the precision of graft placement, minimizing risks and potential complications during surgeries. Innovations like drug-eluting grafts that help prevent infection and restenosis further enhance the efficacy and safety of vascular interventions.

What Role Do Vascular Grafts Play in Treating Vascular Diseases?

Vascular grafts play an indispensable role in the treatment of a range of vascular diseases that can lead to severe complications and even death if left untreated. In patients with coronary artery disease, vascular grafts are used to bypass clogged arteries, helping to restore normal blood flow to the heart. For individuals suffering from peripheral arterial disease, these grafts can bypass diseased arteries in the legs, alleviating symptoms like pain and cramps and preventing limb amputation. In cases of aneurysms, particularly abdominal aortic aneurysms, grafts reinforce weak arterial walls to prevent rupture. The versatility and adaptability of vascular grafts make them essential tools in vascular surgery, providing life-saving treatments for high-risk patients.

Growth in the Vascular Grafts Market Is Driven by Several Factors

The growth in the vascular grafts market is driven by several factors, including the increasing prevalence of cardiovascular diseases globally due to aging populations and rising risk factors such as diabetes, obesity, and hypertension. Technological advancements that improve graft functionality and patient compatibility also contribute to the expansion of this market. There is a growing preference for minimally invasive surgeries, which utilize smaller, more advanced grafts that reduce recovery time and improve patient outcomes. Additionally, the rise in healthcare expenditure and the availability of more sophisticated healthcare facilities in emerging economies are expanding access to vascular graft procedures. Enhanced public awareness about the benefits of early diagnosis and treatment of cardiovascular conditions further stimulates market growth, underscoring the critical nature of vascular grafts in contemporary medical practices.

SCOPE OF STUDY:

The report analyzes the Vascular Grafts market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Indication (Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair, Hemodialysis Access); Raw Material (Polyester, ePTFE, Polyurethane, Biosynthetic); End-Use (Hospitals, Ambulatory Surgical Centers)

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Select Competitors (Total 44 Featured) -

  • Cardinal Health, Inc.
  • Baxter International, Inc.
  • Terumo Corporation
  • Cook Medical, LLC
  • Teleflex, Inc.
  • LeMaitre Vascular, Inc.
  • MicroPort Scientific Corporation
  • iVascular S.L.U
  • Jotec GmbH
  • ParaGen Technologies
  • sunnatech scientific corporation
  • Vacis
  • Cardiovascular Systems, Inc.
  • Healionics
  • InnAVasc Medical

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Vascular Grafts - Global Key Competitors Percentage Market Share in 2024 (E)
    • A Prelude to Vascular Grafting
    • Global Market Prospects and Overview
    • Vascular Grafts Market Set for a Rapid Growth
    • Endovascular Stent-Grafts Account for Larger Share
    • Competition
    • Recent Market Activity
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Incidence of Cardio Vascular Disease Bodes Well for the Global Vascular Graft Market
    • Fatalities by Heart Conditions: Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
    • Global Annual Medical Cost of CVD in US$ Billion (2010-2030)
    • Rising Preference for Minimally Invasive Procedures Boosts Market Prospects
    • Rising Prevalence of Kidney Diseases Drives the Global Hemodialysis Vascular Graft Market
    • Hemodialysis Remains the Major Modality for Dialysis Treatment - A Key Opportunity
    • Global Dialysis Patient Population Distribution by Modality for Select Countries (2020): Percentage Breakdown of Hemodialysis (HD) and Peritoneal Dialysis (PD) Patients
    • Global Population of ESRD Patients Undergoing Therapy by Type of Treatment (2020): Percentage Breakdown of Patients Receiving Hemodialysis, Kidney Transplants, and Peritoneal Dialysis
    • Home Hemodialysis: A Niche Albeit High Potential Market
    • World Dialysis Clinics Market by Region (2019): Percentage Breakdown of Patients Treated by Type of Operator
    • Global Dialysis Market by Region: Percentage Breakdown of Patients Receiving Dialysis Treatment in In-Centre and Home Settings for 2019
    • Aging Population Drives Demand for Vascular Grafts
    • Increasing Healthcare Expenditure to Foster Growth
    • World Healthcare Expenditure (In US$ Trillion) for the Years 2016 & 2018
    • Rising Middle Class Population Aids Growth
    • Global Middle Class Population (in Millions) and as a Percentage of Total Population: 2005, 2015, 2025 & 2035
    • Global Middle Class Spending (in US$ Trillion) by Geographic Region
    • Risk of CAD in Obesity Offers Prospects for Coronary Stenting
    • Obesity Prevalence Rate (%) in Select Countries for the Years 2019 and 2030P
    • Cell-Free Tissue Engineered Vascular Grafts Aid in Vascular Remodeling
    • New Approach for Optimizing TEVGs
    • 3D Printed Vascular Scaffolds Hold Potential to be the New-Age TEVGs
    • A Review of Select Vascular Developments
    • Some of the important vascular innovations expected in the near-term include:
    • Offerings of Moving Analytics and Vasctrac
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair (EVAR) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Endovascular Aneurysm Repair (EVAR) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Endovascular Aneurysm Repair (EVAR) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Peripheral Vascular Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Peripheral Vascular Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Peripheral Vascular Repair by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Hemodialysis Access by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Hemodialysis Access by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Hemodialysis Access by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Polyester by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Polyester by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Polyester by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for ePTFE by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for ePTFE by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for ePTFE by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Polyurethane by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Polyurethane by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Polyurethane by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Biosynthetic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Biosynthetic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Biosynthetic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 24: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Ambulatory Surgical Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Ambulatory Surgical Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 27: World 15-Year Perspective for Ambulatory Surgical Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 28: World Vascular Grafts Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Vascular Grafts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Vascular Grafts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Vascular Grafts by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Vascular Grafts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • JAPAN
    • Vascular Grafts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • CHINA
    • Vascular Grafts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 59: China Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • EUROPE
    • Vascular Grafts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Vascular Grafts by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Vascular Grafts by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Vascular Grafts by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • FRANCE
    • Vascular Grafts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 80: France Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: France 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • GERMANY
    • Vascular Grafts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Germany 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Italy 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Vascular Grafts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 107: UK Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: UK 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Spain 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Spain 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Spain 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Russia 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Russia 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Russia 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Europe 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Vascular Grafts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Asia-Pacific 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Vascular Grafts by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Vascular Grafts by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Vascular Grafts by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • AUSTRALIA
    • Vascular Grafts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Australia 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Australia 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Australia 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • INDIA
    • Vascular Grafts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 164: India Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: India 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
    • TABLE 167: India Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: India 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
    • TABLE 170: India Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: India 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: South Korea 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: South Korea 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: South Korea 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Vascular Grafts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Latin America 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Vascular Grafts by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Vascular Grafts by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Vascular Grafts by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Argentina 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Argentina 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Argentina 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Brazil 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: Brazil 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: Brazil 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: Mexico 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 226: Mexico 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 229: Mexico 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 232: Rest of Latin America 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Latin America 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Latin America 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Vascular Grafts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 241: Middle East 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 244: Middle East 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Vascular Grafts by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Vascular Grafts by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Vascular Grafts by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • IRAN
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 253: Iran 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 256: Iran 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 259: Iran 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 262: Israel 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 265: Israel 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 268: Israel 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 271: Saudi Arabia 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 274: Saudi Arabia 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 277: Saudi Arabia 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 280: UAE 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 283: UAE 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 286: UAE 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 289: Rest of Middle East 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 292: Rest of Middle East 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 295: Rest of Middle East 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • AFRICA
    • Vascular Grafts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 298: Africa 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 301: Africa 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 304: Africa 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030

IV. COMPETITION